LANTHEUS HOLDINGS INC (LNTH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LNTH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LNTH | Director; Executive Chairperson and Chief Executive Officer | 66 | ["Current Executive Chairperson (since November 2025)", "CEO of the Company (since January 2026)", "Former CEO of the Company (August 2015 until March 2024)", "Former Chief Operating Officer of the Company (March 2015 until August 2015)", "Former Chief Commercial Officer of the Company (April 2013 until March 2015)", "B.S., Nursing, City University of New York", "B.S. Biology, State University of New York at Stony Brook", "MBA, Stern School of Business at New York University"] | ["Member", "Science and Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Director since 2015 Chair 66 years old Committees: Science and Technology Committee Specific Expertise: Ms. Heino was chosen as a Director because of her current and former role as our CEO, which gives her an extensive understanding of our business and operations, and because of her broad experience in the pharmaceutical industry. Career Highlights: Current Executive Chairperson (since November 2025) and CEO of the Company (since January 2026) Former CEO of the Company (August 2015 until March 2024) Former Chief Operating Officer of the Company (March 2015 until August 2015) Former Chief Commercial Officer of the Company (April 2013 until March 2015) Education: B.S., Nursing, City University of New York B.S. Biology, State University of New York at Stony Brook MBA, Stern School of Business at New York University